La bourse est fermée

Global Intravenous (IV) Iron Drugs Industry

ReportLinker

Intravenous (IV) Iron Drugs market worldwide is projected to grow by US$943. 8 Billion, driven by a compounded growth of 6. 9%. Ferric Carboxyl Maltose, one of the segments analyzed and sized in this study, displays the potential to grow at over 8.

New York, March 04, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Intravenous (IV) Iron Drugs Industry" - https://www.reportlinker.com/p05151484/?utm_source=GNW
3%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$1.2 Trillion by the year 2025, Ferric Carboxyl Maltose will bring in healthy gains adding significant momentum to global growth.

- Representing the developed world, the United States will maintain a 5.8% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$33.1 Billion to the region’s size and clout in the next 5 to 6 years. Over US$27.6 Billion worth of projected demand in the region will come from Rest of Europe markets. In Japan, Ferric Carboxyl Maltose will reach a market size of US$53.1 Billion by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 10.5% over the next couple of years and add approximately US$268.3 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

- Competitors identified in this market include, among others,

  • Allergan Plc.
  • AMAG Pharmaceuticals Inc.
  • Daiichi Sankyo Inc.
  • Luitpold Pharmaceuticals
  • American Regent Inc.
  • Pharmacosmos A/S
  • Sanofi US
  • Vifor Pharma Ltd.
  • Vifor Fresenius Medical Care Renal Pharma




Read the full report: https://www.reportlinker.com/p05151484/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Iron Deficiency Anemia (IDA) - An Overview
Recent Market Activity
Intravenous (IV) Iron Drugs Market - A Quick Primer
US and Europe Dominate IV Iron Market
Asia-Pacific - The Fastest Growing Market
Leading Intravenous Iron Drugs Globally
Leading IV Iron Drugs Available in the Market
Leading Intravenous Iron Drugs: In a Nutshell
Ferinject/Injectafer - The Leading Intravenous Iron Drug Globally
Venofer® - Looses Ground to Ferinject
Feraheme Obtains Broader Label Approval
Feraheme® Obtains FDA Filing Acceptance for Treating All Adult
Patients Suffering from IDA
Gluconate (Ferrlecit® and Nulecit)
Dextran
Global Market Leaders
Global Competitor Market Shares
Intravenous (IV) Iron Drugs Competitor Market Share Scenario
Worldwide (in %): 2020 & 2029


2. FOCUS ON SELECT PLAYERS

Allergan Plc. (Ireland)
AMAG Pharmaceuticals, Inc. (USA)
Daiichi Sankyo, Inc. (USA)
Luitpold Pharmaceuticals, Inc. (USA)
American Regent, Inc. (USA)
Pharmacosmos A/S (Denmark)
Sanofi US (USA)
Vifor Pharma Ltd. (Switzerland)
Vifor Fresenius Medical Care Renal Pharma (Switzerland)


3. MARKET TRENDS & DRIVERS

Expanding Pool of ESRD and CKD Patients - The Major Growth
Driver for Intravenous (IV) Iron Drugs
ESRD Prevalence Statistics: An Opportunity Indicator
Increase in Healthcare Spending Bodes Well for Intravenous Iron
Drugs Market
Dialysis Patients - A Major Market for Intravenous Iron
Supplements
Ageing Population Drives Demand for IV Iron Drugs
Shifting Preference from Oral Iron Drugs to Intravenous Iron Drugs
Comparison of Ferrous Salts with IV Iron Therapy
Other Chronic Diseases with IDA Offer Prospects for IV Iron Drugs
Anemia in Heart Failure - A Market with Huge Potential
Chemotherapy Induced Anemia to Promote IV Iron Supplements
Correction of IDA in Pregnancy Signals Opportunities
Women?s Health - A Key Growth Opportunity
Perioperative and Postoperative Anemia - A Niche Market Beckons
Adverse Reactions of IV Iron Preparations Raise Concerns
Dosing Limitations Plague IV Iron Market


4. GLOBAL MARKET PERSPECTIVE

Table 1: Intravenous (IV) Iron Drugs Global Market Estimates
and Forecasts in US$ Million by Region/Country: 2018-2025
Table 2: Intravenous (IV) Iron Drugs Global Retrospective
Market Scenario in US$ Million by Region/Country: 2009-2017
Table 3: Intravenous (IV) Iron Drugs Market Share Shift across
Key Geographies Worldwide: 2009 VS 2019 VS 2025
Table 4: Ferric Carboxyl Maltose (Product Type) World Market by
Region/Country in US$ Million: 2018 to 2025
Table 5: Ferric Carboxyl Maltose (Product Type) Historic Market
Analysis by Region/Country in US$ Million: 2009 to 2017
Table 6: Ferric Carboxyl Maltose (Product Type) Market Share
Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS
2025
Table 7: Iron Sucrose (Product Type) Potential Growth Markets
Worldwide in US$ Million: 2018 to 2025
Table 8: Iron Sucrose (Product Type) Historic Market
Perspective by Region/Country in US$ Million: 2009 to 2017
Table 9: Iron Sucrose (Product Type) Market Sales Breakdown by
Region/Country in Percentage: 2009 VS 2019 VS 2025
Table 10: Other Product Types (Product Type) Geographic Market
Spread Worldwide in US$ Million: 2018 to 2025
Table 11: Other Product Types (Product Type) Region Wise
Breakdown of Global Historic Demand in US$ Million: 2009 to
2017
Table 12: Other Product Types (Product Type) Market Share
Distribution in Percentage by Region/Country: 2009 VS 2019 VS
2025
Table 13: Chronic Kidney Disease (Application) Demand Potential
Worldwide in US$ Million by Region/Country: 2018-2025
Table 14: Chronic Kidney Disease (Application) Historic Sales
Analysis in US$ Million by Region/Country: 2009-2017
Table 15: Chronic Kidney Disease (Application) Share Breakdown
Review by Region/Country: 2009 VS 2019 VS 2025
Table 16: Inflammatory Bowel Disease (Application) Worldwide
Latent Demand Forecasts in US$ Million by Region/Country:
2018-2025
Table 17: Inflammatory Bowel Disease (Application) Global
Historic Analysis in US$ Million by Region/Country: 2009-2017
Table 18: Inflammatory Bowel Disease (Application) Distribution
of Global Sales by Region/Country: 2009 VS 2019 VS 2025
Table 19: Cancer (Application) Sales Estimates and Forecasts in
US$ Million by Region/Country for the Years 2018 through 2025
Table 20: Cancer (Application) Analysis of Historic Sales in
US$ Million by Region/Country for the Years 2009 to 2017
Table 21: Cancer (Application) Global Market Share Distribution
by Region/Country for 2009, 2019, and 2025
Table 22: Other Applications (Application) Global Opportunity
Assessment in US$ Million by Region/Country: 2018-2025
Table 23: Other Applications (Application) Historic Sales
Analysis in US$ Million by Region/Country: 2009-2017
Table 24: Other Applications (Application) Percentage Share
Breakdown of Global Sales by Region/Country: 2009 VS 2019 VS
2025


III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Intravenous (IV) Iron Drugs Market Share (in %) by Company:
2020 & 2025
Market Analytics
Table 25: United States Intravenous (IV) Iron Drugs Market
Estimates and Projections in US$ Million by Product Type: 2018
to 2025
Table 26: Intravenous (IV) Iron Drugs Market in the United
States by Product Type: A Historic Review in US$ Million for
2009-2017
Table 27: United States Intravenous (IV) Iron Drugs Market
Share Breakdown by Product Type: 2009 VS 2019 VS 2025
Table 28: United States Intravenous (IV) Iron Drugs Latent
Demand Forecasts in US$ Million by Application: 2018 to 2025
Table 29: Intravenous (IV) Iron Drugs Historic Demand Patterns
in the United States by Application in US$ Million for
2009-2017
Table 30: Intravenous (IV) Iron Drugs Market Share Breakdown in
the United States by Application: 2009 VS 2019 VS 2025
CANADA
Table 31: Canadian Intravenous (IV) Iron Drugs Market Estimates
and Forecasts in US$ Million by Product Type: 2018 to 2025
Table 32: Canadian Intravenous (IV) Iron Drugs Historic Market
Review by Product Type in US$ Million: 2009-2017
Table 33: Intravenous (IV) Iron Drugs Market in Canada:
Percentage Share Breakdown of Sales by Product Type for 2009,
2019, and 2025
Table 34: Canadian Intravenous (IV) Iron Drugs Market
Quantitative Demand Analysis in US$ Million by Application:
2018 to 2025
Table 35: Intravenous (IV) Iron Drugs Market in Canada:
Summarization of Historic Demand Patterns in US$ Million by
Application for 2009-2017
Table 36: Canadian Intravenous (IV) Iron Drugs Market Share
Analysis by Application: 2009 VS 2019 VS 2025
JAPAN
Table 37: Japanese Market for Intravenous (IV) Iron Drugs:
Annual Sales Estimates and Projections in US$ Million by
Product Type for the Period 2018-2025
Table 38: Intravenous (IV) Iron Drugs Market in Japan: Historic
Sales Analysis in US$ Million by Product Type for the Period
2009-2017
Table 39: Japanese Intravenous (IV) Iron Drugs Market Share
Analysis by Product Type: 2009 VS 2019 VS 2025
Table 40: Japanese Demand Estimates and Forecasts for
Intravenous (IV) Iron Drugs in US$ Million by Application: 2018
to 2025
Table 41: Japanese Intravenous (IV) Iron Drugs Market in US$
Million by Application: 2009-2017
Table 42: Intravenous (IV) Iron Drugs Market Share Shift in
Japan by Application: 2009 VS 2019 VS 2025
CHINA
Table 43: Chinese Intravenous (IV) Iron Drugs Market Growth
Prospects in US$ Million by Product Type for the Period
2018-2025
Table 44: Intravenous (IV) Iron Drugs Historic Market Analysis
in China in US$ Million by Product Type: 2009-2017
Table 45: Chinese Intravenous (IV) Iron Drugs Market by Product
Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 46: Chinese Demand for Intravenous (IV) Iron Drugs in US$
Million by Application: 2018 to 2025
Table 47: Intravenous (IV) Iron Drugs Market Review in China in
US$ Million by Application: 2009-2017
Table 48: Chinese Intravenous (IV) Iron Drugs Market Share
Breakdown by Application: 2009 VS 2019 VS 2025
EUROPE
Market Facts & Figures
European Intravenous (IV) Iron Drugs Market: Competitor Market
Share Scenario (in %) for 2020 & 2025
Market Analytics
Table 49: European Intravenous (IV) Iron Drugs Market Demand
Scenario in US$ Million by Region/Country: 2018-2025
Table 50: Intravenous (IV) Iron Drugs Market in Europe: A
Historic Market Perspective in US$ Million by Region/Country
for the Period 2009-2017
Table 51: European Intravenous (IV) Iron Drugs Market Share
Shift by Region/Country: 2009 VS 2019 VS 2025
Table 52: European Intravenous (IV) Iron Drugs Market Estimates
and Forecasts in US$ Million by Product Type: 2018-2025
Table 53: Intravenous (IV) Iron Drugs Market in Europe in US$
Million by Product Type: A Historic Review for the Period
2009-2017
Table 54: European Intravenous (IV) Iron Drugs Market Share
Breakdown by Product Type: 2009 VS 2019 VS 2025
Table 55: European Intravenous (IV) Iron Drugs Addressable
Market Opportunity in US$ Million by Application: 2018-2025
Table 56: Intravenous (IV) Iron Drugs Market in Europe:
Summarization of Historic Demand in US$ Million by Application
for the Period 2009-2017
Table 57: European Intravenous (IV) Iron Drugs Market Share
Analysis by Application: 2009 VS 2019 VS 2025
FRANCE
Table 58: Intravenous (IV) Iron Drugs Market in France by
Product Type: Estimates and Projections in US$ Million for the
Period 2018-2025
Table 59: French Intravenous (IV) Iron Drugs Historic Market
Scenario in US$ Million by Product Type: 2009-2017
Table 60: French Intravenous (IV) Iron Drugs Market Share
Analysis by Product Type: 2009 VS 2019 VS 2025
Table 61: Intravenous (IV) Iron Drugs Quantitative Demand
Analysis in France in US$ Million by Application: 2018-2025
Table 62: French Intravenous (IV) Iron Drugs Historic Market
Review in US$ Million by Application: 2009-2017
Table 63: French Intravenous (IV) Iron Drugs Market Share
Analysis: A 17-Year Perspective by Application for 2009, 2019,
and 2025
GERMANY
Table 64: Intravenous (IV) Iron Drugs Market in Germany: Recent
Past, Current and Future Analysis in US$ Million by Product
Type for the Period 2018-2025
Table 65: German Intravenous (IV) Iron Drugs Historic Market
Analysis in US$ Million by Product Type: 2009-2017
Table 66: German Intravenous (IV) Iron Drugs Market Share
Breakdown by Product Type: 2009 VS 2019 VS 2025
Table 67: Intravenous (IV) Iron Drugs Market in Germany: Annual
Sales Estimates and Forecasts in US$ Million by Application for
the Period 2018-2025
Table 68: German Intravenous (IV) Iron Drugs Market in
Retrospect in US$ Million by Application: 2009-2017
Table 69: Intravenous (IV) Iron Drugs Market Share Distribution
in Germany by Application: 2009 VS 2019 VS 2025
ITALY
Table 70: Italian Intravenous (IV) Iron Drugs Market Growth
Prospects in US$ Million by Product Type for the Period
2018-2025
Table 71: Intravenous (IV) Iron Drugs Historic Market Analysis
in Italy in US$ Million by Product Type: 2009-2017
Table 72: Italian Intravenous (IV) Iron Drugs Market by Product
Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 73: Italian Demand for Intravenous (IV) Iron Drugs in US$
Million by Application: 2018 to 2025
Table 74: Intravenous (IV) Iron Drugs Market Review in Italy in
US$ Million by Application: 2009-2017
Table 75: Italian Intravenous (IV) Iron Drugs Market Share
Breakdown by Application: 2009 VS 2019 VS 2025
UNITED KINGDOM
Table 76: United Kingdom Market for Intravenous (IV) Iron
Drugs: Annual Sales Estimates and Projections in US$ Million by
Product Type for the Period 2018-2025
Table 77: Intravenous (IV) Iron Drugs Market in the United
Kingdom: Historic Sales Analysis in US$ Million by Product Type
for the Period 2009-2017
Table 78: United Kingdom Intravenous (IV) Iron Drugs Market
Share Analysis by Product Type: 2009 VS 2019 VS 2025
Table 79: United Kingdom Demand Estimates and Forecasts for
Intravenous (IV) Iron Drugs in US$ Million by Application: 2018
to 2025
Table 80: United Kingdom Intravenous (IV) Iron Drugs Market in
US$ Million by Application: 2009-2017
Table 81: Intravenous (IV) Iron Drugs Market Share Shift in the
United Kingdom by Application: 2009 VS 2019 VS 2025
SPAIN
Table 82: Spanish Intravenous (IV) Iron Drugs Market Estimates
and Forecasts in US$ Million by Product Type: 2018 to 2025
Table 83: Spanish Intravenous (IV) Iron Drugs Historic Market
Review by Product Type in US$ Million: 2009-2017
Table 84: Intravenous (IV) Iron Drugs Market in Spain:
Percentage Share Breakdown of Sales by Product Type for 2009,
2019, and 2025
Table 85: Spanish Intravenous (IV) Iron Drugs Market
Quantitative Demand Analysis in US$ Million by Application:
2018 to 2025
Table 86: Intravenous (IV) Iron Drugs Market in Spain:
Summarization of Historic Demand Patterns in US$ Million by
Application for 2009-2017
Table 87: Spanish Intravenous (IV) Iron Drugs Market Share
Analysis by Application: 2009 VS 2019 VS 2025
RUSSIA
Table 88: Russian Intravenous (IV) Iron Drugs Market Estimates
and Projections in US$ Million by Product Type: 2018 to 2025
Table 89: Intravenous (IV) Iron Drugs Market in Russia by
Product Type: A Historic Review in US$ Million for 2009-2017
Table 90: Russian Intravenous (IV) Iron Drugs Market Share
Breakdown by Product Type: 2009 VS 2019 VS 2025
Table 91: Russian Intravenous (IV) Iron Drugs Latent Demand
Forecasts in US$ Million by Application: 2018 to 2025
Table 92: Intravenous (IV) Iron Drugs Historic Demand Patterns
in Russia by Application in US$ Million for 2009-2017
Table 93: Intravenous (IV) Iron Drugs Market Share Breakdown in
Russia by Application: 2009 VS 2019 VS 2025
REST OF EUROPE
Table 94: Rest of Europe Intravenous (IV) Iron Drugs Market
Estimates and Forecasts in US$ Million by Product Type:
2018-2025
Table 95: Intravenous (IV) Iron Drugs Market in Rest of Europe
in US$ Million by Product Type: A Historic Review for the
Period 2009-2017
Table 96: Rest of Europe Intravenous (IV) Iron Drugs Market
Share Breakdown by Product Type: 2009 VS 2019 VS 2025
Table 97: Rest of Europe Intravenous (IV) Iron Drugs
Addressable Market Opportunity in US$ Million by Application:
2018-2025
Table 98: Intravenous (IV) Iron Drugs Market in Rest of Europe:
Summarization of Historic Demand in US$ Million by Application
for the Period 2009-2017
Table 99: Rest of Europe Intravenous (IV) Iron Drugs Market
Share Analysis by Application: 2009 VS 2019 VS 2025
ASIA-PACIFIC
Table 100: Asia-Pacific Intravenous (IV) Iron Drugs Market
Estimates and Forecasts in US$ Million by Region/Country:
2018-2025
Table 101: Intravenous (IV) Iron Drugs Market in Asia-Pacific:
Historic Market Analysis in US$ Million by Region/Country for
the Period 2009-2017
Table 102: Asia-Pacific Intravenous (IV) Iron Drugs Market
Share Analysis by Region/Country: 2009 VS 2019 VS 2025
Table 103: Intravenous (IV) Iron Drugs Market in Asia-Pacific
by Product Type: Estimates and Projections in US$ Million for
the Period 2018-2025
Table 104: Asia-Pacific Intravenous (IV) Iron Drugs Historic
Market Scenario in US$ Million by Product Type: 2009-2017
Table 105: Asia-Pacific Intravenous (IV) Iron Drugs Market
Share Analysis by Product Type: 2009 VS 2019 VS 2025
Table 106: Intravenous (IV) Iron Drugs Quantitative Demand
Analysis in Asia-Pacific in US$ Million by Application:
2018-2025
Table 107: Asia-Pacific Intravenous (IV) Iron Drugs Historic
Market Review in US$ Million by Application: 2009-2017
Table 108: Asia-Pacific Intravenous (IV) Iron Drugs Market
Share Analysis: A 17-Year Perspective by Application for 2009,
2019, and 2025
AUSTRALIA
Table 109: Intravenous (IV) Iron Drugs Market in Australia:
Recent Past, Current and Future Analysis in US$ Million by
Product Type for the Period 2018-2025
Table 110: Australian Intravenous (IV) Iron Drugs Historic
Market Analysis in US$ Million by Product Type: 2009-2017
Table 111: Australian Intravenous (IV) Iron Drugs Market Share
Breakdown by Product Type: 2009 VS 2019 VS 2025
Table 112: Intravenous (IV) Iron Drugs Market in Australia:
Annual Sales Estimates and Forecasts in US$ Million by
Application for the Period 2018-2025
Table 113: Australian Intravenous (IV) Iron Drugs Market in
Retrospect in US$ Million by Application: 2009-2017
Table 114: Intravenous (IV) Iron Drugs Market Share
Distribution in Australia by Application: 2009 VS 2019 VS 2025
INDIA
Table 115: Indian Intravenous (IV) Iron Drugs Market Estimates
and Forecasts in US$ Million by Product Type: 2018 to 2025
Table 116: Indian Intravenous (IV) Iron Drugs Historic Market
Review by Product Type in US$ Million: 2009-2017
Table 117: Intravenous (IV) Iron Drugs Market in India:
Percentage Share Breakdown of Sales by Product Type for 2009,
2019, and 2025
Table 118: Indian Intravenous (IV) Iron Drugs Market
Quantitative Demand Analysis in US$ Million by Application:
2018 to 2025
Table 119: Intravenous (IV) Iron Drugs Market in India:
Summarization of Historic Demand Patterns in US$ Million by
Application for 2009-2017
Table 120: Indian Intravenous (IV) Iron Drugs Market Share
Analysis by Application: 2009 VS 2019 VS 2025
SOUTH KOREA
Table 121: Intravenous (IV) Iron Drugs Market in South Korea:
Recent Past, Current and Future Analysis in US$ Million by
Product Type for the Period 2018-2025
Table 122: South Korean Intravenous (IV) Iron Drugs Historic
Market Analysis in US$ Million by Product Type: 2009-2017
Table 123: Intravenous (IV) Iron Drugs Market Share
Distribution in South Korea by Product Type: 2009 VS 2019 VS
2025
Table 124: Intravenous (IV) Iron Drugs Market in South Korea:
Recent Past, Current and Future Analysis in US$ Million by
Application for the Period 2018-2025
Table 125: South Korean Intravenous (IV) Iron Drugs Historic
Market Analysis in US$ Million by Application: 2009-2017
Table 126: Intravenous (IV) Iron Drugs Market Share
Distribution in South Korea by Application: 2009 VS 2019 VS
2025
REST OF ASIA-PACIFIC
Table 127: Rest of Asia-Pacific Market for Intravenous (IV)
Iron Drugs: Annual Sales Estimates and Projections in US$
Million by Product Type for the Period 2018-2025
Table 128: Intravenous (IV) Iron Drugs Market in Rest of
Asia-Pacific: Historic Sales Analysis in US$ Million by Product
Type for the Period 2009-2017
Table 129: Rest of Asia-Pacific Intravenous (IV) Iron Drugs
Market Share Analysis by Product Type: 2009 VS 2019 VS 2025
Table 130: Rest of Asia-Pacific Demand Estimates and Forecasts
for Intravenous (IV) Iron Drugs in US$ Million by Application:
2018 to 2025
Table 131: Rest of Asia-Pacific Intravenous (IV) Iron Drugs
Market in US$ Million by Application: 2009-2017
Table 132: Intravenous (IV) Iron Drugs Market Share Shift in
Rest of Asia-Pacific by Application: 2009 VS 2019 VS 2025
LATIN AMERICA
Table 133: Latin American Intravenous (IV) Iron Drugs Market
Trends by Region/Country in US$ Million: 2018-2025
Table 134: Intravenous (IV) Iron Drugs Market in Latin America
in US$ Million by Region/Country: A Historic Perspective for
the Period 2009-2017
Table 135: Latin American Intravenous (IV) Iron Drugs Market
Percentage Breakdown of Sales by Region/Country: 2009, 2019,
and 2025
Table 136: Latin American Intravenous (IV) Iron Drugs Market
Growth Prospects in US$ Million by Product Type for the Period
2018-2025
Table 137: Intravenous (IV) Iron Drugs Historic Market Analysis
in Latin America in US$ Million by Product Type: 2009-2017
Table 138: Latin American Intravenous (IV) Iron Drugs Market by
Product Type: Percentage Breakdown of Sales for 2009, 2019, and
2025
Table 139: Latin American Demand for Intravenous (IV) Iron
Drugs in US$ Million by Application: 2018 to 2025
Table 140: Intravenous (IV) Iron Drugs Market Review in Latin
America in US$ Million by Application: 2009-2017
Table 141: Latin American Intravenous (IV) Iron Drugs Market
Share Breakdown by Application: 2009 VS 2019 VS 2025
ARGENTINA
Table 142: Argentinean Intravenous (IV) Iron Drugs Market
Estimates and Forecasts in US$ Million by Product Type:
2018-2025
Table 143: Intravenous (IV) Iron Drugs Market in Argentina in
US$ Million by Product Type: A Historic Review for the Period
2009-2017
Table 144: Argentinean Intravenous (IV) Iron Drugs Market Share
Breakdown by Product Type: 2009 VS 2019 VS 2025
Table 145: Argentinean Intravenous (IV) Iron Drugs Addressable
Market Opportunity in US$ Million by Application: 2018-2025
Table 146: Intravenous (IV) Iron Drugs Market in Argentina:
Summarization of Historic Demand in US$ Million by Application
for the Period 2009-2017
Table 147: Argentinean Intravenous (IV) Iron Drugs Market Share
Analysis by Application: 2009 VS 2019 VS 2025
BRAZIL
Table 148: Intravenous (IV) Iron Drugs Market in Brazil by
Product Type: Estimates and Projections in US$ Million for the
Period 2018-2025
Table 149: Brazilian Intravenous (IV) Iron Drugs Historic
Market Scenario in US$ Million by Product Type: 2009-2017
Table 150: Brazilian Intravenous (IV) Iron Drugs Market Share
Analysis by Product Type: 2009 VS 2019 VS 2025
Table 151: Intravenous (IV) Iron Drugs Quantitative Demand
Analysis in Brazil in US$ Million by Application: 2018-2025
Table 152: Brazilian Intravenous (IV) Iron Drugs Historic
Market Review in US$ Million by Application: 2009-2017
Table 153: Brazilian Intravenous (IV) Iron Drugs Market Share
Analysis: A 17-Year Perspective by Application for 2009, 2019,
and 2025
MEXICO
Table 154: Intravenous (IV) Iron Drugs Market in Mexico: Recent
Past, Current and Future Analysis in US$ Million by Product
Type for the Period 2018-2025
Table 155: Mexican Intravenous (IV) Iron Drugs Historic Market
Analysis in US$ Million by Product Type: 2009-2017
Table 156: Mexican Intravenous (IV) Iron Drugs Market Share
Breakdown by Product Type: 2009 VS 2019 VS 2025
Table 157: Intravenous (IV) Iron Drugs Market in Mexico: Annual
Sales Estimates and Forecasts in US$ Million by Application for
the Period 2018-2025
Table 158: Mexican Intravenous (IV) Iron Drugs Market in
Retrospect in US$ Million by Application: 2009-2017
Table 159: Intravenous (IV) Iron Drugs Market Share
Distribution in Mexico by Application: 2009 VS 2019 VS 2025
REST OF LATIN AMERICA
Table 160: Rest of Latin America Intravenous (IV) Iron Drugs
Market Estimates and Projections in US$ Million by Product
Type: 2018 to 2025
Table 161: Intravenous (IV) Iron Drugs Market in Rest of Latin
America by Product Type: A Historic Review in US$ Million for
2009-2017
Table 162: Rest of Latin America Intravenous (IV) Iron Drugs
Market Share Breakdown by Product Type: 2009 VS 2019 VS 2025
Table 163: Rest of Latin America Intravenous (IV) Iron Drugs
Latent Demand Forecasts in US$ Million by Application: 2018 to
2025
Table 164: Intravenous (IV) Iron Drugs Historic Demand Patterns
in Rest of Latin America by Application in US$ Million for
2009-2017
Table 165: Intravenous (IV) Iron Drugs Market Share Breakdown
in Rest of Latin America by Application: 2009 VS 2019 VS 2025
MIDDLE EAST
Table 166: The Middle East Intravenous (IV) Iron Drugs Market
Estimates and Forecasts in US$ Million by Region/Country:
2018-2025
Table 167: Intravenous (IV) Iron Drugs Market in the Middle
East by Region/Country in US$ Million: 2009-2017
Table 168: The Middle East Intravenous (IV) Iron Drugs Market
Share Breakdown by Region/Country: 2009, 2019, and 2025
Table 169: The Middle East Intravenous (IV) Iron Drugs Market
Estimates and Forecasts in US$ Million by Product Type: 2018 to
2025
Table 170: The Middle East Intravenous (IV) Iron Drugs Historic
Market by Product Type in US$ Million: 2009-2017
Table 171: Intravenous (IV) Iron Drugs Market in the Middle
East: Percentage Share Breakdown of Sales by Product Type for
2009, 2019, and 2025
Table 172: The Middle East Intravenous (IV) Iron Drugs Market
Quantitative Demand Analysis in US$ Million by Application:
2018 to 2025
Table 173: Intravenous (IV) Iron Drugs Market in the Middle
East: Summarization of Historic Demand Patterns in US$ Million
by Application for 2009-2017
Table 174: The Middle East Intravenous (IV) Iron Drugs Market
Share Analysis by Application: 2009 VS 2019 VS 2025
IRAN
Table 175: Iranian Market for Intravenous (IV) Iron Drugs:
Annual Sales Estimates and Projections in US$ Million by
Product Type for the Period 2018-2025
Table 176: Intravenous (IV) Iron Drugs Market in Iran: Historic
Sales Analysis in US$ Million by Product Type for the Period
2009-2017
Table 177: Iranian Intravenous (IV) Iron Drugs Market Share
Analysis by Product Type: 2009 VS 2019 VS 2025
Table 178: Iranian Demand Estimates and Forecasts for
Intravenous (IV) Iron Drugs in US$ Million by Application: 2018
to 2025
Table 179: Iranian Intravenous (IV) Iron Drugs Market in US$
Million by Application: 2009-2017
Table 180: Intravenous (IV) Iron Drugs Market Share Shift in
Iran by Application: 2009 VS 2019 VS 2025
ISRAEL
Table 181: Israeli Intravenous (IV) Iron Drugs Market Estimates
and Forecasts in US$ Million by Product Type: 2018-2025
Table 182: Intravenous (IV) Iron Drugs Market in Israel in US$
Million by Product Type: A Historic Review for the Period
2009-2017
Table 183: Israeli Intravenous (IV) Iron Drugs Market Share
Breakdown by Product Type: 2009 VS 2019 VS 2025
Table 184: Israeli Intravenous (IV) Iron Drugs Addressable
Market Opportunity in US$ Million by Application: 2018-2025
Table 185: Intravenous (IV) Iron Drugs Market in Israel:
Summarization of Historic Demand in US$ Million by Application
for the Period 2009-2017
Table 186: Israeli Intravenous (IV) Iron Drugs Market Share
Analysis by Application: 2009 VS 2019 VS 2025
SAUDI ARABIA
Table 187: Saudi Arabian Intravenous (IV) Iron Drugs Market
Growth Prospects in US$ Million by Product Type for the Period
2018-2025
Table 188: Intravenous (IV) Iron Drugs Historic Market Analysis
in Saudi Arabia in US$ Million by Product Type: 2009-2017
Table 189: Saudi Arabian Intravenous (IV) Iron Drugs Market by
Product Type: Percentage Breakdown of Sales for 2009, 2019, and
2025
Table 190: Saudi Arabian Demand for Intravenous (IV) Iron Drugs
in US$ Million by Application: 2018 to 2025
Table 191: Intravenous (IV) Iron Drugs Market Review in Saudi
Arabia in US$ Million by Application: 2009-2017
Table 192: Saudi Arabian Intravenous (IV) Iron Drugs Market
Share Breakdown by Application: 2009 VS 2019 VS 2025
UNITED ARAB EMIRATES
Table 193: Intravenous (IV) Iron Drugs Market in the United
Arab Emirates: Recent Past, Current and Future Analysis in US$
Million by Product Type for the Period 2018-2025
Table 194: United Arab Emirates Intravenous (IV) Iron Drugs
Historic Market Analysis in US$ Million by Product Type:
2009-2017
Table 195: Intravenous (IV) Iron Drugs Market Share
Distribution in United Arab Emirates by Product Type: 2009 VS
2019 VS 2025
Table 196: Intravenous (IV) Iron Drugs Market in the United
Arab Emirates: Recent Past, Current and Future Analysis in US$
Million by Application for the Period 2018-2025
Table 197: United Arab Emirates Intravenous (IV) Iron Drugs
Historic Market Analysis in US$ Million by Application:
2009-2017
Table 198: Intravenous (IV) Iron Drugs Market Share
Distribution in United Arab Emirates by Application: 2009 VS
2019 VS 2025
REST OF MIDDLE EAST
Table 199: Intravenous (IV) Iron Drugs Market in Rest of Middle
East: Recent Past, Current and Future Analysis in US$ Million
by Product Type for the Period 2018-2025
Table 200: Rest of Middle East Intravenous (IV) Iron Drugs
Historic Market Analysis in US$ Million by Product Type:
2009-2017
Table 201: Rest of Middle East Intravenous (IV) Iron Drugs
Market Share Breakdown by Product Type: 2009 VS 2019 VS 2025
Table 202: Intravenous (IV) Iron Drugs Market in Rest of Middle
East: Annual Sales Estimates and Forecasts in US$ Million by
Application for the Period 2018-2025
Table 203: Rest of Middle East Intravenous (IV) Iron Drugs
Market in Retrospect in US$ Million by Application: 2009-2017
Table 204: Intravenous (IV) Iron Drugs Market Share
Distribution in Rest of Middle East by Application: 2009 VS
2019 VS 2025
AFRICA
Table 205: African Intravenous (IV) Iron Drugs Market Estimates
and Projections in US$ Million by Product Type: 2018 to 2025
Table 206: Intravenous (IV) Iron Drugs Market in Africa by
Product Type: A Historic Review in US$ Million for 2009-2017
Table 207: African Intravenous (IV) Iron Drugs Market Share
Breakdown by Product Type: 2009 VS 2019 VS 2025
Table 208: African Intravenous (IV) Iron Drugs Latent Demand
Forecasts in US$ Million by Application: 2018 to 2025
Table 209: Intravenous (IV) Iron Drugs Historic Demand Patterns
in Africa by Application in US$ Million for 2009-2017
Table 210: Intravenous (IV) Iron Drugs Market Share Breakdown
in Africa by Application: 2009 VS 2019 VS 2025


IV. COMPETITION

Total Companies Profiled: 21
Read the full report: https://www.reportlinker.com/p05151484/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001